目前,临床上用于抗惊厥的药物均是对癫癎发作的抑制剂,并不是癫癎原因的治疗药物,(对于小儿痉挛患者应用 ACTH 治疗,实属例外。)当今,控制癫癎发作的药物疗法确实有了很大的进步。血液中抗惊厥药物浓度测定技术的进步,对药物代谢过程的了解都为癫癎的药物疗法做出了贡献。作者就抗癫癎药物治疗中的几个问题作如下介绍: Currently, clinically used drugs for anticonvulsant are both depressants of epileptic seizures and are not therapies for epilepsy, except for the use of ACTH for pediatric spasticity.) Today, therapies that control epileptic seizures Drug therapy has indeed made great progress. Advances in the determination of anticonvulsant drug concentrations in blood have led to the understanding of the drug metabolism process as a contribution to therapies for epilepsy. The authors describe some of the issues in antiepileptic drug treatment as follows: